Stock Events

Stock Events

ARS Pharmaceuticals (SPRY) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.18

-0.14

-0.11

-0.07

Details

Expected EPS

-0.0989

Actual EPS

-0.11

Surprise EPS

-0.01

Surprise Percent

+11.22%

Description

ARS Pharmaceuticals (SPRY) has reported earnings of -0.11 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.